COMMUNIQUÉS West-GlobeNewswire

AtaiBeckley Participates in the 64th Annual ACNP Meeting with Two Scientific Poster Presentations and Hot Topic Presentation
16/01/2026
NEW YORK, Jan. 16, 2026 (GLOBE NEWSWIRE) -- AtaiBeckley Inc. (NASDAQ: ATAI) (“AtaiBeckley” or “Company”), a clinical-stage biotechnology company on a mission to transform patient outcomes by developing rapid-acting, [...]
NRx Pharmaceuticals (Nasdaq:NRXP) Announces 2025 Annual Meeting Date and Record Date
16/01/2026
WILMINGTON, Del., Jan. 16, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) (the “Company”), a clinical-stage biopharmaceutical company, today announced that it will hold its annual meeting of [...]
Profusa Launches Lumee™ Tissue Oxygen Healthcare Research Offerings, Initiating First Commercial Revenue
16/01/2026
Research-use-only offerings are commercially available, enabling immediate product and service revenue generation Targets the global CRO market of $47.9 billion in 2025 and growing at 7% CAGR BERKELEY, Calif, Jan. 16, [...]
Onco360® Has Been Selected as the National Pharmacy Partner for UNLOXCYT™ (cosibelimab-ipdl)
16/01/2026
LOUISVILLE, K.Y., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Onco360 ® , the nation’s leading independent Specialty Pharmacy, has been selected as the national pharmacy partner by Sun Pharmaceuticals for UNLOXCYT ™ (cosibelimab- [...]
Curonix LLC Announces Commercial Availability of the Freedom® Peripheral Nerve Stimulator (PNS) System as the Only Full-Body PNS Therapy Available in the United States for Craniofacial Pain
16/01/2026
POMPANO BEACH, Fla., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Curonix LLC, a leading medical technology company dedicated to relieving chronic pain, today announced the commercial availability of the Freedom ® PNS System for [...]
Vivos Therapeutics Announces Exercise of Warrants for $4.64 Million Gross Proceeds
16/01/2026
LITTLETON, Colo., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (Nasdaq: VVOS), a leading medical device and healthcare services company focused on sleep related breathing [...]
Extendicare Announces Timing of 2025 Fourth Quarter Results and Conference Call
16/01/2026
MARKHAM, Ontario, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it plans to release its financial results for the fourth quarter of 2025 after market [...]
Elicio Therapeutics Reports Inducement Grants
16/01/2026
BOSTON, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of [...]
QHSLab (OTCQB:USAQ) Initiates Board Expansion Process to Strengthen Governance and Support Next Phase of Growth
16/01/2026
Governance evolution follows elimination of major convertible debt, recent funding, and improved capital structure Company advances governance framework aligned with shareholder interests and future listing requirements [...]
182,827 Orion Corporation A shares converted into B shares
16/01/2026
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 16 JANUARY 2026 at 9:30 EET 182,827 Orion Corporation A shares converted into B shares In accordance with [...]
Nouscom Highlights Potential of NOUS-209 to Intercept Cancer in Lynch Syndrome Carriers in Seminal Nature Medicine Publication
16/01/2026
Lynch Syndrome (LS) is a common hereditary condition that significantly increases the lifetime risk of developing multiple cancers NOUS-209 is an off-the-shelf cancer immunotherapy designed to induce T cells against [...]
Bisphenol-free membrane for drinking water applications: Aqua free Industries expands its materials portfolio
16/01/2026
Hamburg / Lommel, 16 January 2026 – Aqua free Industries, a specialist in membrane filters and bespoke OEM solutions within the Aqua free Group, is expanding its range to include bisphenol-free material options for [...]
BridgeBio Prices Offering of $550 Million Convertible Senior Notes due 2033 to Prefund Repayment of Convertible Senior Notes due 2027
16/01/2026
The transaction is part of our strategy to lower interest expense, reduce dilution, and significantly extend debt maturity Offering priced at 0.75% interest rate and 45% conversion premium PALO ALTO, Calif., Jan. 15, [...]
Strongest Adderall Alternative 2026: NeuroXen Report Maps OTC "Adderall Alternative" Search Behavior and a 5-Point Verification Framework
16/01/2026
NeuroXen Editorial Report: "Strongest Adderall Alternative" Reflects Consumer Search Language in 2026 and Does Not Indicate Ranking, Endorsement, Equivalence to Adderall, or Product Effectiveness Pacific Palisades, [...]
Serina Therapeutics Receives NYSE Deficiency Notification Regarding Shareholders' Equity
15/01/2026
HUNTSVILLE, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina” or the "Company") (NYSE American: SER), a clinical-stage biotechnology company advancing its lead Investigational New Drug ("IND") [...]
Liberation Bioindustries Announces New Roles for Founders
15/01/2026
Etan Bendheim assumes role of CEO and Mark Warner moves to CTO role RICHMOND, Ind., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Liberation Bioindustries announces its co-founders have assumed new roles in the company; originally [...]
Strongest Phentermine Alternatives 2026: What OTC Options Actually Exist? Phen24 Consumer Search Analysis and 7-Point Verification Framework
15/01/2026
Phen24 Editorial Report: OTC Appetite Suppressants, Natural Weight Loss Pills, Prescription vs Supplement Standards, and the 7-Point Consumer Verification Framework Los Angeles, California, Jan. 15, 2026 (GLOBE NEWSWIRE [...]
Metabo Drops Investigated: Is It Worth It in 2026? Truth Behind the Liquid Metabolism Drops
15/01/2026
New York City, NY, Jan. 15, 2026 (GLOBE NEWSWIRE) -- As metabolism supplements continue to grow in popularity in 2026, many consumers are seeking clear, factual information to better understand how these products differ [...]
Berberine Moringa NAD+ Patches Gaining Consumer Interest: Guide to Transdermal Supplement Delivery vs. Capsules
15/01/2026
Independent Research Examines Nano Microneedle Technology, Bioavailability Science, and Consumer Evaluation Criteria for Transdermal NAD+ and Berberine Formats SAN LEANDRO, CA, Jan. 15, 2026 (GLOBE NEWSWIRE) -- [...]

Pages